Legal & General Group’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-509
| Closed | -$12K | – | 3596 |
|
|
2021
Q1 | $12K | Hold |
509
| – | – | ﹤0.01% | 3326 |
|
|
2020
Q4 | $10K | Hold |
509
| – | – | ﹤0.01% | 3345 |
|
|
2020
Q3 | $13K | Sell |
509
-122
| -19% | -$3.12K | ﹤0.01% | 3131 |
|
|
2020
Q2 | $18K | Buy |
631
+29
| +5% | +$827 | ﹤0.01% | 3106 |
|
|
2020
Q1 | $29K | Sell |
602
-90
| -13% | -$4.34K | ﹤0.01% | 2776 |
|
|
2019
Q4 | $39K | Buy |
692
+97
| +16% | +$5.47K | ﹤0.01% | 2918 |
|
|
2019
Q3 | $37K | Hold |
595
| – | – | ﹤0.01% | 2866 |
|
|
2019
Q2 | $27K | Hold |
595
| – | – | ﹤0.01% | 3079 |
|
|
2019
Q1 | $38K | Hold |
595
| – | – | ﹤0.01% | 2818 |
|
|
2018
Q4 | $32K | Hold |
595
| – | – | ﹤0.01% | 2879 |
|
|
2018
Q3 | $60K | Hold |
595
| – | – | ﹤0.01% | 2688 |
|
|
2018
Q2 | $40K | Buy |
595
+5
| +0.8% | +$336 | ﹤0.01% | 2861 |
|
|
2018
Q1 | $29K | Sell |
590
-367
| -38% | -$18K | ﹤0.01% | 2987 |
|
|
2017
Q4 | $47K | Sell |
957
-197
| -17% | -$9.68K | ﹤0.01% | 2888 |
|
|
2017
Q3 | $69K | Buy |
1,154
+252
| +28% | +$15.1K | ﹤0.01% | 2810 |
|
|
2017
Q2 | $63K | Buy |
902
+171
| +23% | +$11.9K | ﹤0.01% | 2834 |
|
|
2017
Q1 | $48K | Buy |
731
+2
| +0.3% | +$131 | ﹤0.01% | 2881 |
|
|
2016
Q4 | $69K | Buy |
729
+363
| +99% | +$34.4K | ﹤0.01% | 2770 |
|
|
2016
Q3 | $40K | Hold |
366
| – | – | ﹤0.01% | 2619 |
|
|
2016
Q2 | $30K | Buy |
+366
| New | +$30K | ﹤0.01% | 2737 |
|